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EVALUATION OF LIQUID BACILLUS THURINGIENSIS VAR.
ISRAELENSIS PRODUCTS FOR CONTROL OF AUSTRALIAN AEDES
ARBOVIRUS VECTORS
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ABSTRACT. Laboratory bioassay studies were conducted in southeast Queensland, Australia, on the
efficacy of Teknar', VectoBac"l2AS, and Cybate* (active ingredient: 1,200 international toxic units Bacillus
thuringiensis var. israelensis [Bli]) against 3rd instars of the arbovirus vectors Aedes aegypti, Ae. notoscriptus,
Ae. vigilax, and Ae. camptorhynchus. Probit analyses were then used to determine LDro (median lethal dose),
LDrr, and lethal dose ratios (LDR). Aedes aegypti and Ae. notoscriptus, both container-habitat species, tol-
erated the highest Bti concentrations compared with saltmarsh Ae. vigilax and Ae. camptorhynchus. For ex-
ample, the LDR for Ae. vigilax versus Ae. notoscriptus exposed to Cybate was 0.14 (95Vo confidence limit
[CL] 0.03-0.61). Similarly, the Cybate LDR for Ae. camptorhyaclras versus Ae. notoscriptus wasO.22 (95Vo
CL 0.07-0.70). Teknar produced similar results with an LDR of O.27 (95Vo CL 0.04-1.10) for Aedes vigilax
versus Aedes notoscriptus. Differences in product efficacy were found when tested against the 2 container-
breeding species. Cybate was less effective than Teknar with LDRs of 1.55 (95Vo CL 0.65-3.67) and 1.87
(95Vo CL 0.68-5.15) for Aedes aegypti and Ae. notoscriptus, respectively. The significant differences in
susceptibility between mosquito species and varying efficacy between products highlight the importance of
evaluating concentration-response data prior to contracting with distributors of mosquito control products.
This information is crucial to resistance management strategies.
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INTRODUCTION
Ross River virus (RR), Barmah Forest virus
(BF), and Dengue virus (DEN) types 1-4 seriously
impact human health in Australia (Russell 1998).
Several Aedes species have been implicated in the
transmission of these arboviruses. Aedes campto-
rhynchus (Thompson) has been identified as a vec-
tor of RR (Lindsay et al. 1997), Ae. vigilax (Skuse)
(Kay 1982, Boyd and Kay 1999) and Ae. noto-
scriptus (Skuse) (Watson and Kay 1998, 1999)
have been associated with the transmission of RR
and BF Aedes aegypri (Linn.) is the major vector
of DEN in Australia (Watson and Kay 1999). In the
absence of vaccines for these viruses, we are main-
ly dependent on insecticides to control the mosqui-
to vectors.
Liquid formulations of Bacillus thuringiensis var.
israelensis de Barjac (Bti), an entomopathogenic
bacterium, can control mosquitoes with minimal
environmental impact (Hershey et al. 1995, Brown
et al. 1999). Accordingly, this agent is being ap-
plied with increasing frequency to saltmarsh, man-
grove, and freshwater habitats in Australia. This
broadscale use has stimulated evaluations aimed at
delivering cost-effective Bri applications.
Interspecific differences in susceptibillty to Bti
occur (Mulla et al. 1982, Mahmood 1998). Mah-
mood (1998) found that much higher concentra-
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tions of Bti are required to kill anopheline larvae
that Ae. aegypti (described as a very susceptible
mosquito species). The surface-feeding behavior of
anophelines (Nugud and White 1982) and the feed-
ing rate of Ae. aegypti (Mahmood 1998) have been
suggested as possible causes for these differences.
Crucial to cost-effective insecticide delivery is
the development of concentration-response data for
candidate insecticides and subsequent calculation
of LDro (median lethal concentration) and LD* val-
ues (Roush 1987). Historical records of these val-
ues are invaluable to insecticide resistance manage-
ment strategies (Roush 1987). For resistance
management, Becker and Ludwig (1993) have rec-
ommended that the susceptibility of mosquito pop-
ulations to Bti be checked every 3 years.
Consequently, this study was designed to provide
information on the current susceptibility of 4 spe-
cies of Australian Aedes mosquito to three 1,200
international toxic units (ITU) BtillJrg liquid prod-
ucts. The 3 products were Teknar", VectoBac"l2AS,
and Cybate'. Based on the well-recognized fact that
significant differences in susceptibility to insecti-
cides occur between mosquito species, we hypoth-
esized that 1) signiflcantly different LDto values
would be determined for each of the 4 Aedes spe-
cies, and 2) as the 3 products are all liquids and
have 1,200 ffU Btilmg active ingredient (AI), no
significant differences in efficacy would occur. Us-
ing this data, lethal dose ratios (LDR) (LD'o species
A./LD50 species B) with 95Vo confidence limits (CL)
(Robertson and Preisler 1992) were calculated as a
means of comparing efficacy between species and
products.
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Table 1. Label rates in liters/ha for 3 liquid B/i products against 4 Australia Aedes spp.
Cybate Teknar VectoBacl2AS
Ae. aegypti
Ae, notoscriptus
Ae. vigilax
Ae. camptorhyncus
Not on label
o.3-r.2
0.6-1.2
Not on label
Not on label
0.6-1.2
Not on label
r .2-r .4
Not on label
0.3-0.6
0.6-r.2
Not on label
MATERIALS AND METHODS
Liquid Blf products evaluated
In order to evaluate the efficacy of 1,200 ITU
Btilmg products utilized in field applications, we
tested 1) Teknar (Pacific Biorational, Scarborough,
Queensland, Australia), 2) VectoBacl2AS (Aventis
Environmental Science, East Hawthorn, Victoria,
Australia), and 3) Cybate (Cyanamid Agriculture
Pty. Ltd., Baulkham Hills, New South Wales, Aus-
tralia) (Table l). All batches tested were less than
6 months old and had been stored indoors at 23oC.
Laboratory bioassays
Laboratory bioassays, based on standard meth-
ods for testing of larval susceptibility (World
Health Organization 1981), were used to determine
the concentration-response relationship between the
selected Brl products and the 4 Aedes species. The
Ae. notoscripras (Brisbane colony, 1995, supple-
mented with wild-caught larvae from same locality
in Brisbane in 1997) ar'd, Ae. aegypti (Townsville
colony, 1990, supplemented with wild-caught lar-
vae from the same locality in 1997) larvae used in
these assays were derived from colonies maintained
in the Queensland Institute of Medical Research In-
sectary (Brisbane, Queensland, Australia), using
the methods of Watson et al. (2000a). We believe
that these mosquitoes provided relevant baseline
data on species susceptibility in the region since 1)
neither population had ever been treated with Bri in
the field and 2) both species rarely disperse more
than a few hundred meters (Muir and Kay 1998,
Watson et al. 2000b).
The saltmarsh mosquitos Ae. vigilax (Victoria
Point, Queensland) and Ae. camptorhynchus(Gippsland Lakes, Sale, Victoria) were collected
from the field as early 2nd instars in March 1999.
While the Ae. camptorlrynchus had never been
treated with Bti, the Ae. vigilax population had re-
ceived about 20 treatments with VectoBacG over
the last 2 years.
In the bioassays, the 3rd instars were exposed to
serial dilutions of Bti in water that had been filtered
through a l3o-pm mesh net. The salinity of the test
water was 0 g/liter for the Ae. notoscriptus and, Ae.
aegypti bioassays and 33.5 g4iter habitat water for
the Ae. vigilax and, Ae. camptorhync,has tests. The
various test salinities replicated the habitat water
from which the respective mosquito species were
collected. Five replicates each of twenty 3rd instars
were introduced into 250-ml glass beakers contarn-
ing 200-ml of test concentration. The various test
concentrations were based on the surface area
(0.0034 m2) treated for each 250-nrl glass beaker.
Test specimens were individually removed from
holding trays and distributed randomly among the
test beakers. Five control beakers holding 20 test
larvae each in water without insecticide were used
in each bioassay.
Initially, a number of range-finding tests with
widely spread exposure concentrations were con-
ducted. Based on these tests, a nrurow range ofcon-
centrations that straddle the effective range were
evaluated. The numbers surviving were counted at
24 h. Death or the lack of reaction to gentle prod-
ding with a glass pipette was the measured delete-
rious response. All assays were conducted, at 25'C
under a light:dark cycle of l2:L2h. The test larvae
were not fed during the 24 h of testing to minimize
variability due to nutritional and metabolic condi-
tion.
Statistical methods
Data were analyzed using probit analyses (PROC
PROBIT SAS Institute 1998). In order to compare
Bti efficacy between species and products, LDRs,
along with 95Vo CL, were calculated using the
methods of Robertson and Priesler (1992). Zero
concentrations were analyzed as concentrations of
0.000001 liters/ha to avoid infinite logarithmically
transformed values. This method was adopted in
favor of Abbott's formula (Abbott 1925) because it
does not modify the exposure variable and thus has
negligible impact on the probit curve.
RESULTS
Significantly different LDro and LD", values were
determined for the 3 Bri products tested against the
4 Aedes species (Table 2, Fig. 1). Aedes aegypti and
Ae. notoscriptus tolerated the highest .Bti concen-
trations compared with saltmarsh mosquitoes Ae.
vigilax and Ae. camptorhynchus. For example, the
LDR for Ae. vigilax versus Ae. notoscriptus ex-
posed to Cybate was 0.14 (95Vo CL 0.03-{.61).
Similarly, the Cybate LDR for Ae. camptorhynchus
versus Ae. notoscriptus was O.22 (9580 CL O.O7-
0.70). Teknar produced similar results with an LDR
of O.2l (95Vo CL 0.04-1.10) for Aedes vigilax ver-
sus Aedes notoscriptus. Differences in product ef-
ficacy were found when tested against the 2 con-
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tainer-breeding species. Cybate was less effective
than Teknar, with LDRs of 1.55 (95Vo CL O.65-
3.67) and, 1.87 (957o CL 0.68-5.15) for Aedes ae-
gypti ar:d Ae. notoscrtptus, respectively.
DISCUSSION
This study confirmed our hypothesis that there is
significant variation in susceptibility to Bti between
Australian Aedes species. There was a clear differ-
ence between the susceptibility of the container-
habitat species compared with the saltmarsh (Och-
lerotatus) species. In order to kill 95Vo of Ae.
aegypti, 9.2 (95Vo CL 5.6-15) times more of the
Teknar concentration was required than was needed
to klll 95Vo of Ae. vigilax. However, it was also
notable that, for the saltmarsh species, Ae. camp-
torhynchus required 2.8 (95Vo CL 2-8.5) times the
concentration of Teknar required to kill 957o of Ae.
vigilax.
In contrast with Mahmood (1998), we found Ae.
aegypti was the most Bri-tolerant species evaluated.
Although there are no published differences in for-
aging behavior between the 4 species, ingestion
rates may differ. Based on our results, we recom-
mend that, at a minimum, container habitats hold-
ing Ae. aegypti be treated with these products at a
rate of at least 2literslha. The LDro and LD* data
developed for Ae. aegypti will prove useful to the
respective distributors in Australia, as no label rate
currently exists for this species.
Our hypothesis that the 3 products would all be
equally effective against tllLe 4 Aedes species was
rejected. Cybate was consistently the least effective
product, especially when applied against the con-
tainer-inhabiting mosquito species. In fact, at the
low label rate for Cybate, in clean water, we would
expect between 6O-9OVo of treated Ae. notoscriptus
larvae to survive. Similarly, the label rate for
VectoBacl2AS applications against Ae. notoscrip-
rrs should be increased to O.6-1.2 liters/ha. similar
to that for Teknar. Increasing the rates for these
products will provide a greater safety margin for
application error and compensate for decreases in
product efficacy resulting from environmental and
biological influences in aquatic habitats (Becker et
al. 1992, Nayar et al. 1999).
We can only hypothesize that these differences
in efficacy are related to formulation characteristics.
Although this information is commercially sensi-
tive, one possibility is that the number of particles
on which t}r.e Bti toxins are carried per milligram
varies between products. Teknar and Vecto-
Bacl2AS may be formulated with more particles
than Cybate, which would be available for inges-
tion by feeding larvae. Also, it is commonly known
that producers may increase potency to account for
some losses that occur during formulation process-
es and changes that may take place during shipping
and storage. Therefore, there may be variability in
potency even from one batch to the next. Accord-
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Fig. l. Observed (circles) and predicted (solid line fitted using probit regression equations; dashed lines indicate
95Vo CL) mortality of 4 AustralianAedes mosquitoes treated with 3 x 1,200 ITU Brilmg liquid formulations.
50
25
0
100
= F  7 s
E E  5 0
o <
E q ; 2 5
s <
0
3 roo
3E::q E , u
x $  o
4 g -E t *
o o
= u j 2 5
s <
0
100
E t  t s
< {
E S  5 0
= H  2 s
0
100
75
50
25
0
100
100
75
50
25
0
1.00.10.10.0'l1 .00.1
ingly, we recommend that, where resources permit,
laboratory bioassays be compared with the inter-
national standard IPS-82.
We have provided baseline data on the variable
susceptibility between species to a range of liquid
Bri products. Accordingly, we recorrrmend that
mosquito control agencies evaluate the efficacy of
these products against their local target Aedes.
Products should then be selected using criteria in-
cluding performance and not just price, Also, the
influences on efficacy of various biotic (larval
stage, larval density, feeding behavior) and abiotic
(water temperature, water quality, and water depth)
factors also require definition (Nayar et al. 1999)
with regard to Bri treatments in Australia. This is
important because underdosing our vectors with Bti
could lead to resistance and loss of valuable prod-
ucts.
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